Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.

Clinical trial NCT07512362 · RECRUITING

Trial details

NCT number: NCT07512362
Sponsor: Bernard (Barry) Baumel
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Mild Cognitive Impairment Early Alzheimer's Disease AD-MCI

Start date: 2026-05-15
Primary completion: 2028-06-15
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.